Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT03664271

Educational Eczema Video Intervention

The objectives of this study are to increase families' understanding of eczema and improve eczema management in the primary care setting. The investigators plan to create an educational video for families providing general information about eczema as well as instructions about good skincare management and common treatments. The investigators will conduct a randomized controlled trial of the plan in the primary care clinic at Boston Children's Hospital. Specifically, the investigators aim to (1) decrease eczema severity (2) improve patient and family quality of life (QOL) and (3) increase parental knowledge about eczema and eczema management.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Eczema Congenital, Hereditary, and Neonatal Diseases and Abnormalities Dermatitis Dermatitis, Atopic Genetic Diseases, Inborn Hypersensitivity Hypersensitivity, Immediate Immune System Diseases Skin Diseases Skin Diseases, Eczematous Skin Diseases, Genetic Skin and Connective Tissue Diseases

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Eligibility criteria include the following:

  • accompanying adult speaks English
  • patient has a history of eczema
  • patient is between the ages of 1 month and 16 years
  • accompanying adult is a primary caregiver
  • child is not in foster care
  • accompanying adult is 18 years old or older.

Exclusion criteria

  • accompanying adult does not speak English
  • accompanying adult is not the primary caregiver
  • accompanying adult is not 18 years old or older
  • patient is in foster care

Treatment and study plan

in-clinic video intervention

Behavioral

Video with information about eczema and eczema treatment, to be watched in clinic and at home

at home video intervention

Behavioral

Video with information about eczema and eczema treatment, to be watched at home only

Primary outcomes

  1. change in eczema severity

    Time frame: 3 month follow-up

    eczema severity as measured by the Patient Oriented Eczema Measure (0-28 range, higher score=worse eczema severity)

Secondary outcomes

  1. change in infant quality of life

    Time frame: 3 month follow-up

    infant quality of life as measured by the IDQOL (Infant's Dermatitis Quality of Life Index), uses a 0-30 scale, with a higher number reflecting worse quality of life. Used for children <4 years of age.

  2. change in family quality of life

    Time frame: 3 month follow-up

    family quality of life as measured by the DFI (Dermatitis Family Impact Questionnaire), 0-30 scale with higher score reflecting worse quality of life

  3. change in caregiver knowledge

    Time frame: 3 month follow-up

    change in caregiver knowledge pre-post as assessed by a questionnaire. This is not a standardized tool, but rather a series of 22 questions about caregiver comfort and understanding of eczema. Some responses use a likert scale format, while others are multiple choice questions. There are 8 multiple choice questions, each of which has one right answer. Those can be totaled to determine percentage correct.

  4. change in child quality of life

    Time frame: 3 month follow-up

    child quality of life as measured by the CDLQI (Children's Dermatology Life Quality Index), uses a 0-30 scale, with a higher number reflecting worse quality of life. Used for children age 4-16.

Study contacts

Contact information is provided by the study sponsor or research team.

Corinna Rea, MD, MPH

CONTACT

[email protected]

6173554188

Sponsors and collaborators

Lead sponsor

Boston Children's Hospital

Other

Registry information

Official study title

Randomized Controlled Trial of an Educational Eczema Video

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Sep 10, 2018
Registry last updated
Feb 14, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.